Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - A series of 117 cases

Therapeutics and Clinical Risk Management

Volumn 11, Issue , 2015, Pages 1593-1596

  Vymazal, Tomas ^a   Krecmerova, Martina ^a   Bicek, Vladimír ^a   Lischke, Robert ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

General anesthesia; Myasthenia gravis; Neuromuscular blockade recovery; Sugammadex

Indexed keywords

PROPOFOL; ROCURONIUM; SUFENTANIL; SUGAMMADEX;

ADULT; ANESTHESIA INDUCTION; ANESTHESIOLOGICAL PROCEDURE; ARTICLE; BLOOD CARBON DIOXIDE TENSION; CHOLECYSTECTOMY; COHORT ANALYSIS; FEASIBILITY STUDY; FEMALE; GENERAL ANESTHESIA; HUMAN; LAPAROSCOPIC SURGERY; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKING; OXYGEN SATURATION; PNEUMONIA; POSTOPERATIVE PERIOD; THYMECTOMY;

EID: 84945208687     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S93009     Document Type: Article

References (27)

1. Drachman DB. Myasthenia gravis and other diseases of the neuromuscular junction. In: Harrison’s Principles of Internal Medicine. New York, NY: McGraw-Hill Companies, Inc.; 2008:2672-2677.
2. Valenstein E, Musulin M. Neuromuscular disorders. In: Civetta, Taylor & Kirby’s Critical Care. Philadelphia, PA: Lippincott Williams and Wilkins, A Wolters Kluwer Business; 2009:2235-2241.
3. Bailey PD. Surgical approach to myasthenia gravis. In: Pearson’s Thoracic and Esophageal Surgery. New York, NY: McGraw-Hill Companies, Inc, 2008:655-668.
4. Fennema H, Woo T, Jones K, et al. Sugammadex for rocuronium- or vecuronium-induced blockade reversal: a pooled analysis of 26 controlled studies. Poster presented at: sASA 2013 American Society of Anesthesiologists Annual Meeting; San Francisco, CA. Abstract A4013.
5. Schaller SJ, Fink H. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core Evid. 2013;8:57-67.
6. Adamus M, Gabrhelik T, Marek O. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. Eur J Anaesthesiol. 2008;25:589-595.
7. Racca F, Mongini T, Wolfler A, et al. Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders. Minerva Anesthesiol. 2013;79:419-433.
8. Sundman E, Witt H, Olsson R, et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology. 2000;92:977-984.
9. Eikermann M, Groeben H, Husing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology. 2003;98:1333-1337.
10. Eriksson LI, Sato M, Severinghaus JW. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology. 1993;78:693-699.
11. Bessinger U, Schimek F, Lenz G. Postoperative residual paralysis and respiratory status: a comparative study of pancuronium and vecuronium. Physiol Res. 2000;49:455-462.
12. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003; 98:1042-1048.
13. Baillard C, Bourdiau S, Le Toumelin P, et al. Assessing residual neuromuscular blockade using acceleromyography can be deceptive in postoperative awake patients. Anesth Analg. 2004;98:854-857.
14. Carron M, Veronese S, Foletto M, Ori C. Sugammadex allows fast-track bariatric surgery. Obes Surg. 2013;23:1558-1563.
15. Cerny V, Herold I, Cvachovec K, Sevcik P, Adamus M. Guidelines for managing neuromuscular block: not only Czech beer deserves a taste. Anesth Analg. 2011;112:482.
16. Bartkowski RR. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesth Analg. 1987;66:594-598.
17. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41(9):1095-1103.
18. Sugawara A, Sasakawa T, Hasegawa N, Takahata O, Iwasaki H. Administration of sugammadex to a patient with myasthenia gravis with fade of the train-of-four ratio. Masui. 2011;60:1082-1085.
19. de Boer HD, van Egmond J, Driessen JJ, Booij LH. Sugammadex in patients with myasthenia gravis. Anaesthesia. 2010;65:653.
20. Petrun AM, Mekis D, Kamenik M. Successful use of rocuronium and sugammadex in a patient with myasthenia. Eur J Anaesthesiol. 2010; 27:917-918.
21. Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia. 2010;65:302-305.
22. Garcia V, Diemunsch P, Boet S. Use of rocuronium and sugammadex for caesarean delivery in a patient with myasthenia gravis. Int J Obstet Anesth. 2012;21:286-287.
23. Komasawa N, Noma H, Sugi T, Sukenaga N, Kakiuchi H. Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy. Masui. 2011;60:476-479.
24. Porter MV, Paleologos MS. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal. Anaesth Intensive Care. 2011;39:299-302.
25. Argiriadou H, Anastasiadis K, Thomaidou E, Vasilakos D. Reversal of neuromuscular blockade with sugammadex in an obese myasthenic patient undergoing thymectomy. J Anesth. 2011;25:316-317.
26. de Boer HD, van Egmond J, Driessen JJ, Booij LH. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex. Rev Esp Anestesiol Reanim. 2010;57:181-184.
27. Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in postoperative period. Minerva Anestesiol. 2006;72:97-109.